Da'Marcus Eugene Baymon, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Embolism, Fat | 1 | 2022 | 46 | 0.820 |
Why?
|
| Intracranial Embolism | 1 | 2022 | 188 | 0.730 |
Why?
|
| Workload | 1 | 2023 | 849 | 0.580 |
Why?
|
| Spinal Fractures | 1 | 2022 | 710 | 0.510 |
Why?
|
| Fractures, Bone | 1 | 2022 | 2062 | 0.350 |
Why?
|
| Pulmonary Embolism | 1 | 2022 | 2598 | 0.320 |
Why?
|
| Electronic Health Records | 1 | 2023 | 4881 | 0.260 |
Why?
|
| Triage | 2 | 2023 | 995 | 0.260 |
Why?
|
| Restraint, Physical | 1 | 2023 | 184 | 0.200 |
Why?
|
| Perception | 1 | 2023 | 1205 | 0.140 |
Why?
|
| Emergency Service, Hospital | 6 | 2023 | 7871 | 0.120 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2020 | 505 | 0.120 |
Why?
|
| Inpatients | 2 | 2023 | 2563 | 0.120 |
Why?
|
| Adipose Tissue | 1 | 2020 | 3324 | 0.070 |
Why?
|
| Hippocampus | 1 | 2020 | 3777 | 0.070 |
Why?
|
| Mental Disorders | 1 | 2022 | 6873 | 0.050 |
Why?
|
| Hospitals, Community | 1 | 2023 | 363 | 0.050 |
Why?
|
| Pyrophosphatases | 1 | 2020 | 142 | 0.040 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2020 | 205 | 0.040 |
Why?
|
| Aggression | 1 | 2023 | 748 | 0.040 |
Why?
|
| Long-Term Potentiation | 1 | 2020 | 289 | 0.040 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2020 | 393 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2022 | 59548 | 0.040 |
Why?
|
| Chest Pain | 1 | 2023 | 1101 | 0.030 |
Why?
|
| Humans | 8 | 2023 | 767040 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 12250 | 0.030 |
Why?
|
| Patient Admission | 1 | 2022 | 1364 | 0.030 |
Why?
|
| Synaptic Transmission | 1 | 2020 | 1175 | 0.030 |
Why?
|
| Leptin | 1 | 2020 | 1599 | 0.020 |
Why?
|
| Aged | 1 | 2022 | 171319 | 0.020 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2020 | 1665 | 0.020 |
Why?
|
| Length of Stay | 1 | 2022 | 6489 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 9551 | 0.020 |
Why?
|
| Female | 2 | 2023 | 396660 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2020 | 3986 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2022 | 15925 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2022 | 81659 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 26325 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 22361 | 0.010 |
Why?
|
| Mice | 1 | 2020 | 81912 | 0.010 |
Why?
|
| Middle Aged | 1 | 2023 | 223233 | 0.000 |
Why?
|
| Adult | 1 | 2023 | 223317 | 0.000 |
Why?
|
| Animals | 1 | 2020 | 168965 | 0.000 |
Why?
|